|
|
2Hongbing Li
![]() Summary for 2004 [at-glance overview of Hongbing Li work for the selected year as suggested by data mining algorithms]This is an Authoratory overview of author Hongbing Li. According to available data, in 2004 Hongbing Li published at least 2 articles. In this work Hongbing Li has collaborated exclusively with Villalobo, Antonio resulting in 2 joint articles. There is no information about the funding or the grants awarded to support this work.
Analysis of the article abstracts and the titles suggests that Hongbing Li professional interests are focused around "epidermal growth factor", "growth factor receptor" and "erbb2 neu her2". These might also be referred to as "living cells", "factor receptor" or "epidermal growth". Statistical analysis shows that Hongbing Li's writing is likely to contains terms "cam", "erbb2", "receptor", "egfr", "cells" and "protein".
The majority of Hongbing Li articles are affiliated with Instituto de Investigaciones Biomédicas, Consejo Superior de Investigaciones Científicas and Universidad Autónoma de Madrid, Arturo Duperier 4, E-28029 Madrid, Spain. Sadly, no email addresses were found for any of the affiliations. Images [images we found on the Internet for Hongbing Li]loading...
Do you know Hongbing Li who matches the profile above? Click the photo and let us know!
Alternative names (1) [other authors with names similar to Hongbing Li]Year 2004 Charts [Hongbing Li frequent coauthors and the most common unique vocabulary terms for the selected year]Historical Performance Charts [graphical overview of Hongbing Li publication and funding history for the range of years]Hongbing Li Coauthors (1) [all coauthors with the number of joint publications] Other [context-specific ads]Affiliations (1) [condensed summary of the Hongbing Li affiliations, the leading number and the color conveys importance]- 2Instituto de Investigaciones Biomédicas, Consejo Superior de Investigaciones Científicas and Universidad Autónoma de Madrid, Arturo Duperier 4, E-28029 Madrid, Spain.
Key Opinion Leader In [Hongbing Li is considered a key opinion leader in any keyword where the rank of 5 is achieved, the leading number before the keyword shows the author's rank as compared to all other authors]Keywords (27) [keywords assigned to Hongbing Li articles by PubMed, the leading number and the color conveys importance]- 2Cell Line, Tumor | 2Sulfonamides | 2Humans | 2Phosphorylation | 2Calmodulin | 1Breast Neoplasms | 1Dose-Response Relationship, Drug | 1Adenocarcinoma | 1Signal Transduction | 13' Flanking Region | 1Binding Sites | 1Protein Binding | 1Carcinoma, Squamous Cell | 1Neuregulin-1 | 1Recombinant Proteins | 1Protein Structure, Tertiary | 1Receptor, erbB-2 | 1Calcium | 1Peptides | 1Transfection | 1Genes, erbB-2 | 1Enzyme Inhibitors | 1Mutation | 1Kinetics | 1Calmodulin-Binding Proteins | 1Precipitin Tests | 1Receptor, Epidermal Growth Factor
Hongbing Li Unique Vocabulary (96) [single words, word pairs and phrases obtained by analysis of abstracts and titles, the leading number and the color conveys importance; Hongbing Li might be a good expert witness on these terms]- 14cam | 12erbb2 | 10receptor | 8egfr | 8cells | 6protein | 4calmodulin | 4growth | 4biotinylated | 4ca2 | 4epidermal | 4living | 4factor | 4binds | 4show | 4phosphorylation | 4w7 | 3activity | 3endogenous | 3demonstrate | 3binding | 3interacts | 3using | 3her2 | 2immunoprecipitated | 2sk-br-3 | 2activation | 2previously | 2overlay | 2used | 2vivo | 2dependent
- 4living cells | 4factor receptor | 4epidermal growth | 4growth factor | 3cam binds | 3biotinylated cam | 3neu her2 | 3erbb2 neu | 2phosphorylation activation | 2endogenous calmodulin | 2ca2 dependent | 2sk-br-3 cells | 2interacts epidermal | 2immunoprecipitated erbb2 | 2calmodulin cam | 2binding biotinylated | 2receptor living | 2calmodulin interacts | 2receptor calmodulin-binding | 2calmodulin-binding protein | 2her2 receptor | 2blot analysis | 2erbb2 phosphorylation | 2show w7 | 2signalling pathways | 2western blot | 1prevents binding | 1strictly presence | 1calcineurin activity | 1manner detected | 1human breast | 1kinases show
- 4epidermal growth factor | 4growth factor receptor | 3erbb2 neu her2 | 2endogenous calmodulin interacts | 2interacts epidermal growth | 2factor receptor living | 2calmodulin interacts epidermal | 2receptor living cells | 2receptor calmodulin-binding protein | 2western blot analysis | 2her2 receptor calmodulin-binding | 2neu her2 receptor | 1atf1 activating transcription | 1calmodulin cam binds | 1regulation receptor downstream | 1inhibits phosphorylation activation | 1show w7 inhibits | 1analysis immunoprecipitated erbb2 | 1immunoprecipitated erbb2 preparations | 1increased phosphorylation activation | 1assays biotinylated cam | 1cells cell-permeable cam | 1living cells binding | 1cells overexpress receptor | 1tyrosine kinase activity | 1demonstrate using overlay | 1calcineurin activity moreover | 1levels receptor detectable | 1binds directly immunoprecipitated | 1signalling pathways vivo | 1prevent full transphosphorylation | 1factors operate downstream
Reader's Comments (0) [comments posted by readers of Hongbing Li profile]Funding (0) [selected NIH grants to Hongbing Li and the award amounts for recent years]- award information is not available
Hongbing Li Articles (2) [selected PubMed articles for the year 2004 with the links to a full text at PubMed]The ErbB2/Neu/HER2 receptor is a new calmodulin-binding protein. (2004) >> Instituto de Investigaciones Biomédicas, Consejo Superior de Investigaciones Científicas and Universidad Autónoma de Madrid, Arturo Duperier 4, E-28029 Madrid, Spain. 1Del Carpio, Alan, 2Li, Hongbing, 3Villalobo, Antonio, 1Salas, Valentina, 1Sánchez-Torres, Juan.Endogenous calmodulin interacts with the epidermal growth factor receptor in living cells. (2004) >> Instituto de Investigaciones Biomédicas, Consejo Superior de Investigaciones Científicas and Universidad Autónoma de Madrid, Arturo Duperier 4, E-28029 Madrid, Spain. 2Li, Hongbing, 3Villalobo, Antonio, 1Ruano, María José.
Science Trivia (2) [Interactive math & science trivia questions]
|
|